E2 Ubiquitin-Conjugating Enzymes in Cancer Implications for Immunotherapeutic Interventions
Clinica Chimica Acta 498 (2019) 126–134 Contents lists available at ScienceDirect Clinica Chimica Acta journal homepage: www.elsevier.com/locate/cca Review E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions T Seyed Mohammad Hosseinia,b, Isobel Okoyec, Mitra Ghasemi Chaleshtarid, Bita Hazhirkarzare, Javad Mohamadnejadb, Gholamreza Azizif, Mohammad Hojjat-Farsangig,h, Hamed Mohammadif, ⁎ Siamak Sandoghchian Shotorbania, Farhad Jadidi-Niaraghi,j, a Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran b Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran c Department of Dentistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, T6G 2E1, Canada d Department of Clinical Biochemistry, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran e Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA f Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran g Bioclinicum, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden h The Persian Gulf Marine Biotechnology Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran i Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran j Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran ARTICLE INFO ABSTRACT Keywords: Despite the medical advances of the 21st century, the incidence of cancer continues to increase and the search for E2 conjugating enzymes a universal cure remains a major health challenge. Our lack of understanding the complex pathophysiology of Ubiquitin the tumor microenvironment has hindered the development and efficiency of anti-cancer therapeutic strategies.
[Show full text]